PQQ is a redox cofactor that plays a crucial role in the function of several enzymes involved in energy metabolism. It is also known for its powerful antioxidant properties, which help in neutralizing free radicals - unstable molecules that can cause cellular damage. The body's ability to manage oxidative stress is particularly vital during viral infections, including COVID-19, where the immune response generates a significant amount of reactive oxygen species (ROS).
The process of developing an API typically involves several stages, starting with research and development (R&D). This phase includes the identification of potential drug candidates, preclinical studies, and clinical trials to establish safety and efficacy. Once promising candidates are identified, the focus shifts to optimizing the synthesis process to ensure scalability and cost-effectiveness. This often requires collaboration between chemists, biologists, and pharmaceutical scientists to fine-tune the production parameters.